Article
Impact of genomic background and developmental state on signaling pathways and response to therapy in glioblastoma patient-derived cells
2024-03-16
Abstract excerpt
Glioblastoma (GBM) tumors represents diverse genomic epigenomic, and transcriptional landscapes, with significant intratumoral heterogeneity that challenges standard of care treatments involving radiation (RT) and the DNA-alkylating agent temozolomide (TMZ). In this study, we employed targeted proteomics to assess the response of a genomically-diverse panel of GBM patient-derived cancer stem cells (CSCs) to astroc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5a576ca1-e709-51ce-a14d-474691f891bb
- DOI
- 10.1101/2024.03.14.585115
